Connected Drug Delivery Devices Market Industry Outlook, Share, and Forecast 2034

The global connected drug delivery devices market share in 2026 is witnessing rapid expansion, driven by the increasing adoption of digital healthcare technologies and the rising demand for patient-centric treatment solutions. According to Fortune Business Insights, the global connected drug delivery devices market size was valued at USD 2.15 billion in 2025. The market is projected to grow from USD 2.50 billion in 2026 to USD 8.54 billion by 2034, exhibiting a CAGR of 16.59% during the forecast period. North America dominated the global market with a share of 70.06% in 2025.

Connected drug delivery devices are advanced systems integrated with digital technologies such as sensors, Bluetooth connectivity, and mobile applications that enable real-time monitoring and tracking of medication usage. These devices play a crucial role in improving patient adherence, optimizing treatment outcomes, and enabling healthcare providers to access valuable patient data for better decision-making.

Rising Adoption of Digital Health Solutions to Fuel Market Growth

The increasing penetration of digital health solutions is a key factor driving the growth of the connected drug delivery devices market. With the growing burden of chronic diseases such as diabetes, asthma, and chronic obstructive pulmonary disease (COPD), there is a rising need for efficient drug delivery systems that ensure timely and accurate medication administration.

Connected devices help patients track their medication schedules, receive reminders, and share data with healthcare professionals. This improved engagement significantly enhances treatment adherence, which is a major challenge in chronic disease management. Additionally, the integration of artificial intelligence and cloud-based platforms is further enhancing the functionality and efficiency of these devices.

Increasing Prevalence of Chronic Diseases Driving Demand

The growing prevalence of chronic diseases across the globe is significantly contributing to the demand for connected drug delivery devices. Conditions such as diabetes require continuous monitoring and precise drug administration, making connected insulin pens and inhalers highly beneficial.

Moreover, the aging population and the increasing need for home-based healthcare solutions are boosting the adoption of these devices. Patients prefer convenient and easy-to-use solutions that allow them to manage their health independently without frequent hospital visits.

Technological Advancements Enhancing Device Capabilities

Technological advancements in healthcare devices are playing a pivotal role in shaping the market landscape. Innovations such as smart inhalers, connected autoinjectors, and wearable drug delivery systems are transforming the way medications are administered.

These devices are equipped with advanced features such as dose tracking, real-time data transmission, and integration with mobile applications. This enables healthcare providers to monitor patient adherence remotely and adjust treatment plans accordingly. Furthermore, the use of data analytics is helping in identifying patterns and improving overall treatment outcomes.

Top Companies In The

• Proteus Digital Health

• Ypsomed Holding

• F. Hoffmann-La Roche Ltd

• BD

• West Pharmaceutical Services

• Propeller Health (A ResMed Company)

• Adherium

• Cohero Health, Inc.

Market Drivers & Restraints:

Drivers: The market is primarily driven by the increasing need for improved medication adherence, growing adoption of connected healthcare technologies, and rising investments in digital health infrastructure. The demand for personalized medicine and remote patient monitoring solutions is also fueling market growth.

Restraints: Despite significant growth potential, the market faces challenges such as high costs associated with connected devices, concerns related to data privacy and security, and limited awareness in developing regions. Regulatory complexities may also hinder market expansion to some extent.

Market Report Coverage:

The market report provides comprehensive insights into various aspects of the connected drug delivery devices market. It includes detailed analysis of market size, growth trends, competitive landscape, and key industry developments. The report also covers technological advancements, regulatory scenarios, and strategic initiatives undertaken by leading players.

Additionally, it offers in-depth segmentation analysis based on product type, application, end-user, and region. The report highlights emerging opportunities and provides valuable recommendations for stakeholders to make informed business decisions.

Market Competitive Landscape:

The connected drug delivery devices market is highly competitive, with several key players focusing on innovation and strategic collaborations to strengthen their market position. Companies are investing in research and development activities to introduce advanced products with enhanced features.

Partnerships, mergers, and acquisitions are common strategies adopted by market players to expand their product portfolios and geographic presence. The competitive landscape is characterized by the presence of both established companies and emerging startups, contributing to dynamic market growth.

Market Segments:

The market is segmented based on product type, application, and end-user.

By Type (Injectable Devices and Inhalation Devices & Others)

By Technology (Bluetooth, NFC, and Others)

By End User (Homecare Settings and Hospitals)

Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/industry-reports/connected-drug-delivery-devices-market-100380 

Market Regional Insights:

North America dominated the connected drug delivery devices market in 2025, accounting for a share of 70.06%. The region’s dominance is attributed to the presence of advanced healthcare infrastructure, high adoption of digital health technologies, and strong presence of key market players.

Europe is also witnessing significant growth due to increasing healthcare expenditure and growing awareness about connected healthcare solutions. Meanwhile, the Asia Pacific region is expected to register the highest growth rate during the forecast period, driven by improving healthcare infrastructure, rising patient population, and increasing adoption of advanced medical technologies.

Future Market Scope:

The future of the connected drug delivery devices market looks promising, with continuous advancements in technology and increasing focus on patient-centric care. The integration of artificial intelligence, machine learning, and Internet of Things (IoT) is expected to revolutionize the market.

Furthermore, the growing emphasis on preventive healthcare and personalized medicine will create new opportunities for market expansion. Companies are likely to focus on developing cost-effective and user-friendly devices to cater to a wider patient population.

June 2021 - Adherium Limited announced that they submitted their 510(k) application to the U.S. FDA for the market clearance of their first generation Hailie sensor which has physiological measures to monitor Asthma and COPD medication use.

Contact us:

Fortune Business Insights™ Pvt.

Phone: USA: +1 833 909 2966 (Toll-Free),

United Kingdom: +44 808 502 0280 (Toll-Free),

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com